These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25046214)

  • 1. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.
    Kirsch M; Götz A; Halter JP; Schanz U; Stussi G; Dobbels F; De Geest S
    Bone Marrow Transplant; 2014 Sep; 49(9):1223-30. PubMed ID: 25046214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.
    Rovó A; Daikeler T; Halter J; Heim D; Tsakiris DA; Stern M; Waltimo T; Studt JD; Tyndall A; Gratwohl A; Tichelli A
    Haematologica; 2011 Jan; 96(1):150-5. PubMed ID: 20851864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.
    Pophali PA; Klotz JK; Ito S; Jain NA; Koklanaris E; Le RQ; Hourigan CS; Savani BN; Chawla K; Shanbhag S; Barrett AJ; Battiwalla M
    Exp Hematol; 2014 Feb; 42(2):83-9. PubMed ID: 24141092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
    Martino R; Caballero MD; Canals C; Simón JA; Solano C; Urbano-Ispízua A; Bargay J; Rayón C; Léon A; Sarrá J; Odriozola J; Conde JG; Sierra J; San Miguel J; ;
    Br J Haematol; 2001 Dec; 115(3):653-9. PubMed ID: 11736950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
    Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Fujisawa S; Onishi Y; Yano S; Onizuka M; Kanda Y; Mizuno I; Taniguchi S; Yamashita T; Inamoto Y; Okamoto S; Atsuta Y
    Bone Marrow Transplant; 2019 Apr; 54(4):611-615. PubMed ID: 30287939
    [No Abstract]   [Full Text] [Related]  

  • 7. Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).
    Lazarevic VL; Labopin M; Depei W; Yakoub-Agha I; Huynh A; Ljungman P; Schaap N; Cornelissen JJ; Maillard N; Pioltelli P; Gedde-Dahl T; Lenhoff S; Houhou M; Esteve J; Mohty M; Nagler A
    Am J Hematol; 2018 Jan; 93(1):31-39. PubMed ID: 28971504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study.
    Hwang JP; Roundtree AK; Giralt SA; Suarez-Almazor M
    BMJ Support Palliat Care; 2012 Dec; 2(4):344-50. PubMed ID: 24654219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
    Shigematsu A; Kobayashi N; Yasui H; Shindo M; Kakinoki Y; Koda K; Iyama S; Kuroda H; Tsutsumi Y; Imamura M; Teshima T
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):801-5. PubMed ID: 24565990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
    Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
    Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
    Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
    BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation.
    Jim HS; Sutton SK; Jacobsen PB; Martin PJ; Flowers ME; Lee SJ
    Cancer; 2016 Apr; 122(8):1290-7. PubMed ID: 26814442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related risk behaviors among myocardial infarction survivors in the United States: A propensity score matched study.
    Yegezu Z; Mollon L; Alshayban DM; Bilal J; Bhattacharjee S
    Res Social Adm Pharm; 2021 Feb; 17(2):307-314. PubMed ID: 32360124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum testosterone levels in long-term adult survivors with fatty liver after childhood stem cell transplantation.
    Hyodo H; Ishiguro H; Tomita Y; Takakura H; Koike T; Shimizu T; Morimoto T; Yabe H; Yabe M; Kojima S; Shiraishi K; Minemura T; Kato S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1119-27. PubMed ID: 22248714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
    Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
    Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.
    Dufour C; Rondelli R; Locatelli F; Miano M; Di Girolamo G; Bacigalupo A; Messina C; Porta F; Balduzzi A; Iorio AP; Buket E; Madon E; Pession A; Dini G; Di Bartolomeo P; ;
    Br J Haematol; 2001 Mar; 112(3):796-805. PubMed ID: 11260086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation.
    Felder-Puig R; Peters C; Matthes-Martin S; Lamche M; Felsberger C; Gadner H; Topf R
    Bone Marrow Transplant; 1999 Jul; 24(1):75-80. PubMed ID: 10435739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.
    Tessoulin B; Ceballos P; Chevallier P; Blaise D; Tournilhac O; Gauthier J; Maillard N; Tabrizi R; Choquet S; Carras S; Ifrah N; Guillerm G; Mohty M; Tilly H; Socie G; Cornillon J; Hermine O; Daguindau É; Bachy E; Girault S; Marchand T; Oberic L; Reman O; Leux C; Le Gouill S
    Bone Marrow Transplant; 2016 Sep; 51(9):1184-90. PubMed ID: 27111043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.